Occult Hepatitis B Virus infection in a cohort of patients with chronic Hepatitis C

<p><strong>Introduction</strong>: The prevalence of occult hepatitis B, defi ned by absence of HBsAg and HBV DNA, ranges widely in patients with hepatitis C. This may infl uence the treatment of hepatitis C and the severity of liver disease</p><p><strong>Aim of wo...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: MI Naga (Autor), MA Amin (Autor), DA Algendy (Autor), AI El Badry (Autor), MM Fawzi (Autor), AR Foda (Autor), SM Esmat (Autor), SM Gabal (Autor), D Sabry (Autor), M Kamal (Autor), LA Rashed (Autor)
Formato: Libro
Publicado: Archives of Hepatitis Research - Peertechz Publications, 2019-07-26.
Materias:
Acceso en línea:Connect to this object online.
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

MARC

LEADER 00000 am a22000003u 4500
001 peertech__10_17352_ahr_000022
042 |a dc 
100 1 0 |a MI Naga  |e author 
700 1 0 |a  MA Amin  |e author 
700 1 0 |a  DA Algendy  |e author 
700 1 0 |a  AI El Badry  |e author 
700 1 0 |a  MM Fawzi  |e author 
700 1 0 |a  AR Foda  |e author 
700 1 0 |a  SM Esmat  |e author 
700 1 0 |a  SM Gabal  |e author 
700 1 0 |a  D Sabry  |e author 
700 1 0 |a  M Kamal  |e author 
700 1 0 |a  LA Rashed  |e author 
245 0 0 |a Occult Hepatitis B Virus infection in a cohort of patients with chronic Hepatitis C 
260 |b Archives of Hepatitis Research - Peertechz Publications,   |c 2019-07-26. 
520 |a <p><strong>Introduction</strong>: The prevalence of occult hepatitis B, defi ned by absence of HBsAg and HBV DNA, ranges widely in patients with hepatitis C. This may infl uence the treatment of hepatitis C and the severity of liver disease</p><p><strong>Aim of work and methods</strong>: Was to determine the prevalence of occult hepatitis B virus infection and liver of HBsAg negative patients with chronic hepatitis C and to evaluate its clinical consequences on liver pathology and its impact on the response to treatment with peg-IFNa and Ribavirin. Immunohistochemistry staining for hepatitis B surface antigen and HBV DNA detection was assessed retrospectively on liver biopsies of HCV positive/ HBsAg negative patients before treatment.</p> 
540 |a Copyright © MI Naga et al. 
546 |a en 
655 7 |a Research Article  |2 local 
856 4 1 |u https://doi.org/10.17352/ahr.000022  |z Connect to this object online.